Binh Hoang, MBA is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Summary
- I am currently a part of NIH Covid-19 Research team. I have been involved heavily with both the Remdesivir and Moderna Phase 1 studies.
Over 18 years of experience in Clinical Trial Management - Expertise areas include:
• Knowledge of Export and Import pharmaceutical product regulations and requirements
• Directly contact pharmaceutical manufacturers on behalf of sponsor to obtain study products for NIH sponsored HIV clinical trials.
• Familiar with Harmonized Tariff Schedule Codes and Export Commodity Classification
• Contributed to researching and developing a Guide for Importing Pharmaceutical Regulations (for clinical trials) for 20 countries
• Manage and deal with customs broker and freight forwarders
• Respond and interact with FDA’s, DEA’s and other government’s requests
• Experience working with 300 clinical sites in 20 countries
• Experience in writing government contract proposals - Review and analyze the requirements of the solicitation. Research, write and edit materials for proposal.
• Develop and implement Standard Operational Practices (SOPs)
• Serve as primary liaison to clinical site pharmacists in 20 countries
• Clinical trial experience – knowledge of design and implementation of clinical trials
• Clinical supplies distribution for HIV clinical trials.
• Evaluate and analyze HIV clinical trial protocols
• Forecast study supply for protocols
• Knowledge of Good Clinical Practice guidelines
Education & Training
New England CollegeMBA, Health Informatics, 2014 - 2015
Howard UniversityPharmD, 1999
Awards, Honors, & Recognition
- NIH DIRECTOR'S AWARD 2021 NIH, 2021
- Dean's List 1992-1998
- Scholarship Howard University, 1997
- Join now to see all
Publications & Presentations
PubMed
- Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.Wolfe CR, Tomashek KM, Patterson TF, Gomez CA, Marconi VC, Jain MK, Yang OO, Paules CI, Palacios GMR, Grossberg R, Harkins MS, Mularski RA, Erdmann N, Sandkovsky U, Al...> ;The Lancet. Respiratory medicine. 2022-05-23
- Homologous and Heterologous Covid-19 Booster Vaccinations.Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, ...> ;The New England journal of medicine. 2022-01-26
- Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine...> ;The Lancet. Respiratory medicine. 2021-10-18
- Join now to see all
Lectures
- New Therapy for Wilson's diseaseHoward University Hospital, D.C.
- Pharmacy Benefit ManagementHeath Information Design, Inc., Fairfax, VA
- Aminoglycoside DosingWalter Reed Army Medical Center, D.C.
- Join now to see all
Other Languages
- Vietnamese
Office
5601 Fishers Lane
North Bethesda, MD 20852- Is this information wrong?
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
